Parenteral artesunate access programme aims at reducing malaria fatality rates in South Africa.
نویسندگان
چکیده
April 2011, Vol. 101, No. 4 SAMJ Disclaimer. The opinions expressed in this paper are those of the authors and do not represent the views of government, industry or any NGO. Conflicts of interest. No authors have any conflict of interest to declare. Dr Spencer received honoraria from Aspen, Adcock Ingram, GSK and MSD in the past 12 months. Participants. Professors Sharon Cassol and Maureen Taylor; Drs Lynne Webber, Francis Akpan, Andy Beke, Masese Beke, Mariette Botes, Sheila Bowyer, Marieke Brauer, Vivian Cox, Judith Dlamini, Nicollette du Plessis, Hashim Ebrahim, Marcelle Erasmus, Ute Feucht, Allison Glass, Ebrahim Hoosien, Evelyn Kangawasa, Fritz Kinkel, Sim Mayaphi, Daniël Morobadi, Rolando Viani, Marianne Swanepoel, John Sim and Adele Visser; and Messrs Glen Malherbe and Neil Morris.
منابع مشابه
Falling Plasmodium knowlesi Malaria Death Rate among Adults despite Rising Incidence, Sabah, Malaysia, 2010–2014
Deaths from Plasmodium knowlesi malaria have been linked to delayed parenteral treatment. In Malaysia, early intravenous artesunate is now recommended for all severe malaria cases. We describe P. knowlesi fatalities in Sabah, Malaysia, during 2012-2014 and report species-specific fatality rates based on 2010-2014 case notifications. Sixteen malaria-associated deaths (caused by PCR-confirmed P. ...
متن کاملArtesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial
BACKGROUND Severe malaria is a major cause of childhood death and often the main reason for paediatric hospital admission in sub-Saharan Africa. Quinine is still the established treatment of choice, although evidence from Asia suggests that artesunate is associated with a lower mortality. We compared parenteral treatment with either artesunate or quinine in African children with severe malaria....
متن کاملPrereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis.
BACKGROUND Severely ill patients with malaria with vomiting, prostration, and altered consciousness cannot be treated orally and need injections. In rural areas, access to health facilities that provide parenteral antimalarial treatment is poor. Safe and effective treatment of most severe malaria cases is delayed or not achieved. Rectal artesunate interrupts disease progression by rapidly reduc...
متن کاملArtesunate: The Best Drug in the Treatment of Severe and Complicated Malaria
This review summarizes progress in treating severe and complicated malaria, which are global problems, claiming at least one million lives annually, and have been accompanied by advances in our understanding of the pathogenesis of severe malaria complications. New drugs such as intravenous artesunate (AS) and intramuscular artemether (AM) are improving outcomes and decreasing malaria deaths. Tr...
متن کاملUpdate on Cases of Delayed Hemolysis After Parenteral Artesunate Therapy for Malaria — United States, 2008 and 2013
Parenteral artesunate, a first-line treatment for severe malaria in several countries, is associated with increased survival and has a better safety profile compared with parenteral quinine or quinidine. However, parenteral artesunate has been associated with delayed hemolysis, leading to concerns about drug toxicity. Postartemisinin delayed hemolysis (PADH) can occur 1-3 weeks after initiation...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde
دوره 101 4 شماره
صفحات -
تاریخ انتشار 2011